Meeting the Clinical Needs of Patients
Nubratori RX currently has 12 products on the market.
These products are sold under the FDA Structured Product Listing,
Market Category, C181659: Outsourcing Facility Compounded Human Drug Product
(Exempt From Approval Requirements). Click image to enlarge.
Lidocidex™ is an injectable sterile formulation consisting of lidocaine and dexamethasone.
Lidomar™ is an injectable sterile formulation consisting of lidocaine and bupivicane.
Nubratori RX currently has ten additional products in the pipeline designed for non-opiate pain control for orthopedics, neurologists, and others in the pain management health care sector.
Nubratori RX products are batch tested, validated, and put through the required stability and potency testing prior to being released to the market.
Let us know how we can help you.